| Market Cap | 513M 449M 414M 382M 726M 48.95B 738M 4.95B 1.94B 24.11B 1.93B 1.89B 82.89B | P/E 2017 |
-17.4x | P/E 2018 | -41.8x |
|---|---|---|---|---|---|
| Enterprise Value | 460M 402M 371M 343M 651M 43.88B 662M 4.44B 1.74B 21.62B 1.73B 1.69B 74.32B | EV / Sales 2017 |
53,919,197x | EV / Sales 2018 | 19,487,976x |
| Free-Float |
80.58% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -8.86% | - | - | 352M | |
| +0.95% | -0.08% | -12.93% | -8.82% | 12.85B | |
| +2.42% | +1.37% | -33.67% | -54.78% | 4.79B | |
| -0.02% | -0.64% | -7.44% | -9.90% | 4.4B | |
| +2.11% | -0.70% | +3.95% | -37.98% | 3.82B | |
| -7.84% | -7.31% | +11.66% | -9.08% | 3.68B | |
| -0.58% | +6.63% | -8.62% | -12.78% | 3.26B | |
| +0.28% | +0.57% | -11.17% | +2.10% | 3.1B | |
| -0.77% | +1.24% | -8.23% | -23.20% | 2.41B | |
| -0.32% | +4.78% | -5.15% | +44.22% | 1.8B | |
| Average | -0.38% | -1.14% | -7.95% | -12.25% | 4.46B | |
| Weighted average by Cap. | -0.01% | -1.26% | -9.82% | -15.18% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 3.08 2.69 2.48 2.29 4.35 293.56 4.43 29.67 11.65 144.62 11.56 11.31 497.16 | 18.69 16.35 15.08 13.93 26.43 1.78K 26.87 180.2 70.76 878.28 70.19 68.66 3.02K |
| Net income | -8.89M -7.78M -7.17M -6.63M -12.57M -848M -12.78M -85.71M -33.66M -418M -33.38M -32.66M -1.44B | -8.41M -7.36M -6.79M -6.27M -11.9M -802M -12.1M -81.11M -31.85M -395M -31.59M -30.9M -1.36B |
| Net Debt | -1.84M -1.61M -1.48M -1.37M -2.6M -175M -2.64M -17.73M -6.96M -86.4M -6.9M -6.75M -297M | -53.08M -46.43M -42.82M -39.55M -75.05M -5.06B -76.31M -512M -201M -2.49B -199M -195M -8.57B |
Employees
-
Sector
Pharmaceuticals
Choose MarketScreener 
